While mutations in APC or other components of the β-catenin destruction complex are primarily responsible for hyperactivated β-catenin, several other molecules, such as DKK1, WIF1, Sox17, etc., regulate β-catenin activation and are linked to CRC pathogenesis (34–37). The gene discussed is APC; the disease is colorectal carcinoma.